The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...

In August, the agency warned that many people are overdosing on alternatives to Ozempic and Wegovy due to the do-it-yourself ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

The company's semaglutide injection—better known by the brand names Ozempic and Wegovy—has become well-known for its weight-loss results and ability to manage diabetes. And while there are several ...

The semaglutide family of drugs, which includes Ozempic as well as Wegovy, which can be prescribed on the NHS to those with Type 2 diabetes, are medications that mimic the hormone GLP-1 (glucagon-like ...

Danish pharma giant Novo Nordisk has said it is aware of at least 10 deaths and 100 hospitalisations linked to compounded ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular weight loss drugs.

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.